Evaluation of Comprehensive Cancer Control (CCC) Efforts to Promote HPV and HBV Vaccination
The vaccine preventable cancers workgroup of the National Comprehensive Cancer Control Partnership (CCCNP) has developed an evaluation resource to help CCC coalitions to evaluate their efforts in promoting Hepatitis B (HBV) and human papillomavirus (HPV) vaccination. This resource has been developed to evaluate the areas of partnership enhancement and communication that CCC coalitions are likely to focus on in promoting HPV and HBV vaccination.
View PDF
Learn About It! What is the tool?
- To address needs identified by coalition representatives, the CCCNP Vaccine Preventable Cancers Workgroup developed a logic model that outlines common coalition strategies, activities, and outcomes related to partnership enhancement and communication related to promoting HPV and HBV vaccination (figure 1). This logic model aligns with the NCCCP strategies in the 5-year notice of funding opportunity (NOFO) logic model, particularly supporting partnerships for cancer prevention and control, delivering and implementing evidence-based interventions and conducting program monitoring and evaluation.
- Each logic model strategy is mapped to specific evaluation questions, concepts, indicators, data sources, and data collection methods in an accompanying evaluation matrix.
- Developed with input from CDC subject matter experts and coalition partners, this tool provides cancer coalitions with a roadmap for the types of questions and information needed to best evaluate their efforts in improving vaccination rates through partnership enhancement and communication efforts.
- Ideally, coalitions would use this tool at the beginning of a new initiative for promoting HPV and/or HBV vaccination.
- Use it to as plan coalition activities and select associated evaluation metrics at the outset.
- Engagement of coalition members and other relevant partners and community members will help in the selection of appropriate and feasible activities and relevant outcomes to evaluate.
- Coalitions can also use this tool after activities to promote HPV and/or HBV vaccination have begun.
- Identify aligned evaluation metrics and data sources for activities underway.
- Work with implementing partners to determine feasibility, timelines, and workflow/responsibilities for data collection and analysis to ensure that the most meaningful data are gathered and reported.
Strategy 1: Develop and Enhance Partnerships to Promote Vaccination.
Evaluation Question | Concept Tested | Indicator | Data Source | Data Collection Method |
(1) To what extent does the CCC coalition enhance partnerships to promote HBV and HPV vaccination? | Partnership Development and Support |
|
CCC meeting minutes, correspondences, and documents |
|
Strategy 2: Facilitate and Enhance Communication of Evidence Based Interventions
Evaluation Question | Concept Tested | Indicator | Data Source | Data Collection Method |
(2a) To what extent is the CCC coalition increasing knowledge of evidence-based interventions (EBI) to improve vaccination uptake among CCC coalition partners serving under-immunized populations? (2b) To what extent has the increased knowledge of the EBIs led to action among CCC coalition partners? | Communication and Awareness |
|
Survey of coalition partners to assess:
|
|
Strategy 3: Facilitate and Enhance Communication about Vaccination Data
Evaluation Question | Concept Tested | Indicator | Data Source | Data Collection Method |
(3a) To what extent is the coalition communicating about data on barriers and facilitators to vaccine uptake and vaccination coverage among under-immunized populations? (3b) To what extent has the increased knowledge of data about barriers to vaccine uptake and vaccination coverage led to action among CCC partners serving under-immunized populations? | Dissemination and Use of Data |
|
|
|
Outcome: Increase HPV/HBV Vaccination Amount Populations Experiencing Disparities
Evaluation Question | Concept Tested | Indicator | Data Source | Data Collection Method |
(4)To what extent does the CCC coalition increase access to immunization services including among priority populations and/or communities experiencing disparities? | Participation by priority population Outreach to community and to providers |
|
|
|